Zhicong Zhao

Shanghai, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications

A hepatocyte circFADS2-HNRNPD-P2RY1 axis restrains arachidonic acid output and tunes alloimmune injury in pediatric liver transplantation.

A hepatocyte circFADS2-HNRNPD-P2RY1 axis restrains arachidonic acid output and tunes alloimmune injury in pediatric liver transplantation.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Published: February 20, 2026

UFMylation Suppresses Hepatocellular Carcinoma Metastasis by Inhibiting β-Catenin-Driven Hybrid EMT and NK Cell Evasion.

UFMylation Suppresses Hepatocellular Carcinoma Metastasis by Inhibiting β-Catenin-Driven Hybrid EMT and NK Cell Evasion.

Journal: Cancer research
Published: October 20, 2025

Liver ischemia-reperfusion promotes tumor metastasis via neutrophil-endothelial interactions: targeting ICAM1 to prevent metastatic recurrence.

Liver ischemia-reperfusion promotes tumor metastasis via neutrophil-endothelial interactions: targeting ICAM1 to prevent metastatic recurrence.

Journal: Journal of translational medicine
Published: September 02, 2025

Mesenchymal stem cell-derived exosomes as cell-free therapeutics: mechanistic insights and engineering strategies for liver disease treatment.

Mesenchymal stem cell-derived exosomes as cell-free therapeutics: mechanistic insights and engineering strategies for liver disease treatment.

Journal: Stem cell research & therapy
Published: August 12, 2025

Targeting YTHDF2 impacts the epitranscriptome and overcomes tumor therapy resistance.

Targeting YTHDF2 impacts the epitranscriptome and overcomes tumor therapy resistance.

Journal: Trends in cell biology
Published: January 29, 2025

Cell therapies and liver organogenesis technologies: Promising strategies for end-stage liver disease.

Cell therapies and liver organogenesis technologies: Promising strategies for end-stage liver disease.

Journal: Hepatology (Baltimore, Md.)
Published: January 21, 2025

YTHDF2 upregulation and subcellular localization dictate CD8 T cell polyfunctionality in anti-tumor immunity.

YTHDF2 upregulation and subcellular localization dictate CD8 T cell polyfunctionality in anti-tumor immunity.

Journal: Nature communications
Published: December 19, 2023

The roles and therapeutic implications of messenger RNA internal N7 -methylguanosine and N6 -methyladenosine modifications in chemoresistance.

The roles and therapeutic implications of messenger RNA internal N7 -methylguanosine and N6 -methyladenosine modifications in chemoresistance.

Journal: Clinical and translational medicine
Published: August 22, 2023

METTL16 promotes liver cancer stem cell self-renewal via controlling ribosome biogenesis and mRNA translation.

METTL16 promotes liver cancer stem cell self-renewal via controlling ribosome biogenesis and mRNA translation.

Journal: Journal of hematology & oncology
Published: April 19, 2023

Phosphorylation stabilized TET1 acts as an oncoprotein and therapeutic target in B cell acute lymphoblastic leukemia.

Phosphorylation stabilized TET1 acts as an oncoprotein and therapeutic target in B cell acute lymphoblastic leukemia.

Journal: Science translational medicine
Published: March 29, 2023

RNA m6A reader YTHDF2 facilitates precursor miR-126 maturation to promote acute myeloid leukemia progression.

RNA m6A reader YTHDF2 facilitates precursor miR-126 maturation to promote acute myeloid leukemia progression.

Journal: Genes & diseases
Published: November 27, 2022

Suppression of YTHDF2 attenuates autoimmune hepatitis by expansion of myeloid-derived suppressor cells.

Suppression of YTHDF2 attenuates autoimmune hepatitis by expansion of myeloid-derived suppressor cells.

Journal: Journal of autoimmunity
Published: September 26, 2022
Showing 1-12 of 24

Last Updated: 09/26/2026